Efficacy and Safety Enrolling by Invitation Phase 4 Trials for Mycophenolate mofetil (DB00688)

IndicationStatusPhase
DBCOND0085675 (Efficacy and Safety)Enrolling by Invitation4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02809079Mycophenolate Mofetil Treatment With Neuromyelitis Optica Spectrum Disorders in Chinese PatientsTreatment